Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Contraindications Based on mechanisms and theoretical considerations, BPC-157 may not be appropriate for: Individuals with active cancer Pregnant or breastfeeding women Those with uncontrolled cardiovascular conditions People taking anticoagulant medications (effects on bleeding unknown) Individuals with autoimmune conditions (immune modulation effects unclear) Quality and Purity Concerns Perhaps the most significant safety concern involves product quality
Peptides are short chains of amino acids that naturally occur in the body and play important roles in cellular repair and inflammation regulation
Slower titration equals better tolerance
AOD-9604 is experimental, not FDA-approved, and should not be viewed as a therapy for medical use
HHS has announced that GHK-Cu is expected to return to Category 1, which would restore compounding access for injectable formulations. BPC-157 On 23 July 2026, PCAC voted to recommend adding BPC-157 to the 503A Bulks List, in opposition to the FDA staff review, which had recommended against listing
Monthly shots combined with dietary intake of fortified foods and animal products can help older adults meet their dietary needs and reduce the risk of age-related deficiency
